Kangrin And Boqe Pharmaceutical Private Limited, a active private limited company, was established on 28 November 2003 in Thane, Maharashtra, India. Engaging in api manufacturers within the trade sector, it holds CIN: U24231MH2003PTC143320. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Ashish Shrimanth Ghosh (Director), Nilesh Pravin Lokhande (Additional Director). Past directors included Sambhu Nath Paul, Pradip Kumar Pal, Sudip Paul. It holds ₹4.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 212 Blossom Chsraheja Complex Kalyan West, Thane, Maharashtra.
U24231MH2003PTC143320
143320
28 November 2003
₹0.50 M
₹0.50 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Kangrin And Boqe Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ashish Shrimanth Ghosh | Director | 25 Jan 2021 | Current |
| Nilesh Pravin Lokhande | Additional Director | 20 May 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Managing Director | 10 Mar 2019 | Past |
| Pramod Abcsdd | Director | 04 Apr 2019 | Past |
| Pramod Abcsdd | Director | 20 May 2025 | Past |
| Pramod Abcsdd | Director | 04 Apr 2019 | Past |
| Pramod Abcsdd | Director | 01 Feb 2023 | Past |
| Pramod Abcsdd | Director | 04 Apr 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Logus Labortries Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 29.28% decrease. The company also saw a substantial fall in profitability, with a 22.39% decrease in profit. The company's net worth Soared by an impressive increase of 262.56%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Kangrin And Boqe Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹40,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Jun 2025 | Canara Bank | ₹4.00 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Kangrin And Boqe Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Kangrin And Boqe Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kangrin And Boqe Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Canara Bank amounted to Rs. 40.00 M with Charge ID 101139261 was registered on 20 Jun 2025. was completed.
Nilesh Pravin Lokhande was appointed as a Additional Director was appointed as a Additional Director on 20 May 2025 & has been associated with this company since 6 months 11 days . was recorded as a recent event.
Kangrin And Boqe Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Kangrin And Boqe Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Ashish Shrimanth Ghosh was appointed as a Director was appointed as a Director on 25 Jan 2021 & has been associated with this company since 4 years 10 months . was recorded as a recent event.
The activity Kangrin And Boqe Pharmaceutical Private Limited was registered on 28 Nov 2003 with Roc Mumbai & aged 22 years 1 day as per MCA records. was completed.
The CIN of Kangrin And Boqe Pharmaceutical Private Limited is U24231MH2003PTC143320.
Kangrin And Boqe Pharmaceutical Private Limited is headquartered at 212 Blossom Chsraheja Complex Kalyan West, Thane, Maharashtra.
Kangrin And Boqe Pharmaceutical Private Limited was incorporated on 28 November 2003.
The current directors of Kangrin And Boqe Pharmaceutical Private Limited are
The primary industry of Kangrin And Boqe Pharmaceutical Private Limited is Trade.
Kangrin And Boqe Pharmaceutical Private Limited is unlisted.
The authorized capital of Kangrin And Boqe Pharmaceutical Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Kangrin And Boqe Pharmaceutical Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX